AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 FEB 11 - (NewsRx.com & NewsRx.net) -- BioPort Corporation announced that the Lansing-based manufacturer of the world's only U.S. Food and Drug Administration (FDA) licensed anthrax vaccine has entered into a 3-year contract to continue supplying the vaccine to the Pentagon.
"This contract demonstrates the Pentagon's faith in our company and underscores the importance of the vaccine as the centerpiece of protection against a bioterrorist attack," BioPort president Bob Kramer said.
The $245-million contract for anthrax vaccine doses was awarded to BioPort on December 31, 2003. The contract allows the Pentagon flexibility in the number of doses to be delivered, giving the option to increase the number over the 3 years.
"Federal officials recently re-stated their concerns about the level of vulnerability in the event of a massive airborne anthrax attack. This contract allows other agencies such as Homeland Security, Health and Human Services, and the State Department to obtain ...